Last reviewed · How we verify

NCT05773365

PENG Block Plus Local Infiltration Compared to PENG Block Alone in Hip Surgery

Active, enrolled NA Last updated 18 December 2024
What this trial tests

NA trial testing PENG block with or without local anaesthetic infiltration in Pain in 122 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
18 July 2023
Primary endpoint
1 May 2025
1 July 2025

Quick facts

Lead sponsorSuez Canal University
PhaseNA
StatusActive, enrolled
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment122
Start date18 July 2023
Primary completion1 May 2025
Estimated completion1 July 2025
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Suez Canal University

Who can join

Adults 18 to 80, any sex, with Pain or Hip Fractures. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Summary: Pain control after hip surgery is quite important for patients' recovery. Many regional techniques are available with the focus on motor sparing block to speed patient recovery. The investigators will compare pericapsular nerve group (PENG) block in addition to local skin infiltration to PENG block alone. The study population will be included for patient traumatic hip surgery. The study population will be divided into group. First group will receive PENG block and local anaesthetics infiltration and second group will receive PENG block. Our primary outcome is to compare numeric rating scale (NRS) between studied groups, and morphine requirements in the first 24 hours as a secondary outcome.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Pain

Currently open trials in the same condition.

Other Suez Canal University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05773365.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing